Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Ferric pyrophosphate citrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for ferric pyrophosphate citrate and what is the scope of ferric pyrophosphate citrate freedom to operate?

Ferric pyrophosphate citrate
is the generic ingredient in one branded drug marketed by Rockwell Medical Inc and is included in two NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ferric pyrophosphate citrate has thirty patent family members in twenty countries.

There are fourteen drug master file entries for ferric pyrophosphate citrate. Two suppliers are listed for this compound.

Summary for Generic Name: ferric pyrophosphate citrate

Tradenames:1
Patents:4
Applicants:1
NDAs:2
Drug Master File Entries: see list14
Suppliers / Packagers: see list2
Clinical Trials: see list283
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ferric pyrophosphate citrate at DailyMed

Pharmacology for Ingredient: ferric pyrophosphate citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rockwell Medical Inc
TRIFERIC
ferric pyrophosphate citrate
SOLUTION;IV (INFUSION)206317-002Sep 4, 2015RXYesNo► Subscribe► Subscribe
Rockwell Medical Inc
TRIFERIC
ferric pyrophosphate citrate
FOR SOLUTION;INTRAVENOUS208551-001Apr 25, 2016RXYesYes► Subscribe► Subscribe
Rockwell Medical Inc
TRIFERIC
ferric pyrophosphate citrate
SOLUTION;IV (INFUSION)206317-001Jan 23, 2015RXYesYes7,816,404► SubscribeY ► Subscribe
Rockwell Medical Inc
TRIFERIC
ferric pyrophosphate citrate
SOLUTION;IV (INFUSION)206317-001Jan 23, 2015RXYesYes6,689,275► Subscribe ► Subscribe
Rockwell Medical Inc
TRIFERIC
ferric pyrophosphate citrate
SOLUTION;IV (INFUSION)206317-001Jan 23, 2015RXYesYes6,779,468► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot